IL-7 promotes long-term in vitro survival of unique long-lived memory subset generated from mucosal effector memory CD4+ T cells in chronic colitis mice

Immunology Letters

Volumn 156, Issue 1-2, 2013, Pages 82-93

  Takahara, Masahiro ^a,c   Nemoto, Yasuhiro ^a   Oshima, Shigeru ^a   Matsuzawa, Yu ^a   Kanai, Takanori ^b   Okamoto, Ryuichi ^a   Tsuchiya, Kiichiro ^a   Nakamura, Tetsuya ^a   Yamamoto, Kazuhide ^c   Watanabe, Mamoru ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c OKAYAMA UNIVERSITY   (Japan)

Author keywords

CD4; Cell culture; IL 7; Inflammatory bowel disease; Memory T cells

Indexed keywords

ALPHA4BETA7 INTEGRIN; BACTERIAL ANTIGEN; CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON; INTEGRIN; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7; PROTEIN BCL 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL ISOLATION; CELL SURVIVAL; CHRONIC COLITIS; COLITIS; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HISTOLOGY; IN VITRO STUDY; IN VIVO STUDY; LAMINA PROPRIA; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE;

BM; BONE MARROW; CD4; CELL CULTURE; CENTRAL MEMORY T (CELLS); EFFECTOR MEMORY T (CELLS); IBD; IL-7; INFLAMMATORY BOWEL DISEASE; LAMINA PROPRIA; LP; MEMORY T CELLS; MESENTERIC LYMPH NODES; MLNS; REGULATORY T (CELLS); SP; SPLEEN; T(CM); T(EM); T(REG);

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD45; CD4-POSITIVE T-LYMPHOCYTES; CELL SURVIVAL; CHRONIC DISEASE; COLITIS; CYTOKINES; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; IMMUNOLOGIC MEMORY; INTEGRIN ALPHA4; INTEGRIN BETA CHAINS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-7; INTESTINAL MUCOSA; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, SCID; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, CXCR3; T-LYMPHOCYTE SUBSETS; TIME FACTORS;

EID: 84885996417     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2013.09.001     Document Type: Article

References (25)

1. Abraham C., Cho J.H. Inflammatory bowel disease. N Engl J Med 2009, 361:2066-2078. [Review].
2. Rutgeerts P., Sandborn W.J., Feagan B.G., Reinisch W., Olson A., Johanns J., et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 2005, 353:2462-2476.
3. Totsuka T., Kanai T., Nemoto Y., Tomita T., Tsuchiya K., Sakamoto N., et al. Immunosenescent colitogenic CD4+ T cells convert to regulatory cells and suppress colitis. Eur J Immunol 2008, 38:1275-1286.
4. Lopez-Cubero S.O., Sullivan K.M., McDonald G.B. Course of Crohn's disease after allogeneic marrow transplantation. Gastroenterology 1998, 1114:433-440.
5. Mueller S.N., Gebhardt T., Carbone F.R., Heath W.R. Memory T cell subsets, migration patterns, and tissue residence. Annu Rev Immunol 2012, 10.1146/annurev-immunol-032712-095954.
6. Gattinoni L., Lugli E., Ji Y., Pos Z., Paulos C.M., Quigley M.F., et al. A human memory T cell subset with stem cell-like properties. Nat Med 2011, 17:1290-1297.
7. Gattinoni L., Klebanoff C.A., Restifo N.P. Paths to stemness: building the ultimate antitumour T cell. Nat Rev Cancer 2012, 12:671-684.
8. Sallusto F., Lanzavecchia A. Memory in disguise. Nat Med 2011, 17:1182-1183.
9. Cong Y., Brandwein S.L., McCabe R.P., Lazenby A., Birkenmeier E.H., Sundberg J.P., et al. CD4+ T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice: increased T helper cell type 1 response and ability to transfer disease. J Exp Med 1998, 187:855-864.
10. Nemoto Y., Kanai T., Takahara M., Oshima S., Okamoto R., Tsuchiya K., et al. Th1/Th17-mediated interstitial pneumonia in chronic colitis mice independent of intestinal microbiota. J Immunol 2013, 190:6616-6625.
11. Sprent J., Surh C.D. Normal T cell homeostasis: the conversion of naive cells into memory-phenotype cells. Nat Immunol 2011, 12:478-484. [Review].
12. Surh C.D., Boyman O., Purton J.F., Sprent J. Homeostasis of memory T cells. Immunol Rev 2006, 211:154-163. [Review].
13. + T cells penetrate gut epithelial monolayers and egress from lamina propria to blood circulation. Gastroenterology 2011, 141:2130-2139.
14. Sprent J., Surh C.D. T cell memory. Annu Rev Immunol 2002, 20:551-579.
15. Seddon B., Tomlinson P., Zamoyska R. Interleukin 7 and T cell receptor signals regulate homeostasis of CD4 memory cells. Nat Immunol 2003, 4:680-686.
16. Wherry E.J., Barber D.L., Kaech S.M., Blattman J.N., Ahmed R. Antigen-independent memory CD8 T cells do not develop during chronic viral infection. Proc Natl Acad Sci USA 2004, 101:16004-16009.
17. Ahmed R., Bevan M.J., Reiner S.L., Fearon D.T. The precursors of memory: models and controversies. Nat Rev Immunol 2009, 9:662-668.
18. Harrington L.E., Janowski K.M., Oliver J.R., Zajac A.J., Weaver C.T. Memory CD4 T cells emerge from effector T-cell progenitors. Nature 2008, 452:356-360.
19. Boyman O., Sprent J. The role of interleukin-2 during homeostasis and activation of the immune system. Nat Rev Immunol 2012, 12:180-190.
20. Dooms H., Wolslegel K., Lin P., Abbas A.K. Interleukin-2 enhances CD4+ T cell memory by promoting the generation of IL-7R alpha-expressing cells. J Exp Med 2007, 204(3):547-557.
21. Kameyama K., Nemoto Y., Kanai T., Shinohara T., Okamoto R., Tsuchiya K., et al. IL-2 is positively involved in the development of colitogenic CD4+ IL-7R alpha high memory T cells in chronic colitis. Eur J Immunol 2010, 40:2423-2436.
22. Triplett T.A., Curti B.D., Bonafede P.R., Miller W.L., Walker E.B., Weinberg A.D. Defining a functionally distinct subset of human memory CD4+ T cells that are CD25POS and FOXP3NEG. Eur J Immunol 2012, 42:1893-1905.
23. Caserta S., Alessi P., Basso V., Mondino A. IL-7 is superior to IL-2 for ex vivo expansion of tumour-specific CD4(+) T cells. Eur J Immunol 2010, 40:470-479.
24. Kondrack R.M., Harbertson J., Tan J.T., McBreen M.E., Surh C.D., Bradley L.M. Interleukin 7 regulates the survival and generation of memory CD4 cells. J Exp Med 2003, 198:1797-1806.
25. Lynch D.H., Miller R.E. Interleukin 7 promotes long-term in vitro growth of antitumor cytotoxic T lymphocytes with immunotherapeutic efficacy in vivo. J Exp Med 1994, 179:31-42.